For instance, Eli Lilly is working on a once-weekly oral GLP-1 receptor agonist, potentially revolutionizing the administration of these drugs
Lancet Diabetes Endocrinol (2019) 7:60617
I had it on both sides of my family, and trying to avoid those kinds of things will, I think, help longevity for me, she continued
The Evidence: Some small human trials and animal studies have suggested modest improvements in blood glucose control, with indirect evidence of GLP-1 involvement
On December 4, 2025, the Judicial Panel on Multidistrict Litigation (JPML) heard arguments for creating a group lawsuit for people who lost their vision after taking Mounjaro and other GLP-1 drugs
People taking injectable semaglutide can lose on average 15 percent of their weight while a clinical trial found that more than one-third of participants on tirzepatide lost 25 percent of their weight over 72 weeks